Comparing radiofrequency treatment and corticosteroid injection for hip osteoarthritis pain
Continuous Radiofrequency in Hip Osteoarthritis Pain: A Protocol of a Randomized Clinical Trial
This study is testing whether a new radiofrequency treatment works better than a steroid injection for relieving pain and improving movement in people with hip osteoarthritis.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Brasilia Academic / other |
| Locations | 1 site (Brasília, Federal District) |
| Trial ID | NCT06221709 on ClinicalTrials.gov |
What this trial studies
This clinical trial is designed to evaluate the effectiveness of Conventional Radiofrequency (CRF) treatment compared to intraarticular corticosteroid injection in managing pain and improving function in patients with hip osteoarthritis. The study will be conducted at Hospital SARAH in Brasília, utilizing a double-blinded, randomized approach to ensure unbiased results. Participants will undergo sedation or general anesthesia, and the procedures will be performed under fluoroscopic guidance to ensure accurate placement of the treatment. The trial aims to provide insights into the best pain management strategies for individuals suffering from this condition.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 18 and older with symptomatic unilateral hip osteoarthritis grades II and III, experiencing pain for more than six months.
Not a fit: Patients with specific exclusions such as radiculopathy, previous hip surgeries, or other significant medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more effective pain management option for patients with hip osteoarthritis.
How similar studies have performed: Other studies have shown promising results with similar approaches, indicating potential for success in this trial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals ≥ 18 years of age, with symptomatic unilateral hip osteoarthritis, grades II and III according to the Kellgreen and Lawrance classification, hip pain for more than six months (medial, anterior, anterolateral, and/or lateral region) will be included. Exclusion Criteria: * Individuals with radiculopathy and ipsilateral irradiation, osteonecrosis of the femoral head, previous arthroplasty on the hip to be studied or surgical scar that could lead to changes in the anatomy of the hip, cases of high dislocation of the hip, pain exclusively in the posterior region, symptomatic ipsilateral knee osteoarthritis, intra-articular infiltration of corticosteroids or hyaluronic acid in the hip for less than six months, patients with neurological diseases, peripheral neuropathy or psychiatric diseases, use of a pacemaker or Prothrombin Activity Time (INR) \> 3.
Where this trial is running
Brasília, Federal District
- Rede Sarah Hospitais de Reabilitação — Brasília, Federal District, Brazil (Recruiting)
Study contacts
- Study coordinator: Gilvan F Vaz, MD
- Email: gilvanvaz@gmail.com
- Phone: 5561991527220
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.